Chlamydia trachomatis+Neisseria gonorrhoeae point of care test
Jump to navigation
Jump to search
Introduction
Point of care test.
Indications
- evaluation of Chlamydia trachomatis Neisseria gonorrhoeae infection
Clinical significance
Methods
- point of care test, results in 30 minutes
- processes a single-use cartridge
- samples collected using female vaginal swabs & male urine specimens
Notes
More general terms
Additional terms
- Chlamydia trachomatis
- Chlamydia trachomatis + Neisseria gonorrhoeae DNA (GenProbe, Amplicor)
- Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
- Neisseria gonorrhoeae (gonococcus, GC)
References
- ↑ Van Der Pol B, Taylor SN, Mena L et al Evaluation of the Performance of a Point-of-Care Test for Chlamydia and Gonorrhea. JAMA Netw Open. 2020;3(5):e204819. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32407506 Free Article https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2765941
- ↑ FDA News Release March 30, 2021 FDA Allows for First Point-of-Care Chlamydia and Gonorrhea Test to be Used in More Near-Patient Care Settings. https://www.fda.gov/news-events/press-announcements/fda-allows-first-point-care-chlamydia-and-gonorrhea-test-be-used-more-near-patient-care-settings